BRCA 1/2的临床试验
总计16249个结果
-
National Institute of Diabetes and Digestive and...终止
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
University of Illinois at Urbana-ChampaignLouisiana State University Health Sciences Center in New Orleans; Colorado State University; A...完全的
-
University Hospital, Caen完全的
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; Ronald and Rita McAulay Foundation主动,不招人
-
Royal Devon and Exeter NHS Foundation TrustUniversity of Exeter主动,不招人
-
Second Xiangya Hospital of Central South University完全的
-
Massachusetts General HospitalBeta Bionics, Inc.撤销
-
Radboud University Medical Center未知
-
Vanderbilt University完全的
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZeneca主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | BRIP1基因突变 | PALB2基因突变 | ATM基因突变 | CHEK2基因突变 | NBN基因突变 | RAD51基因突变 | 体细胞突变乳腺癌 (BRCA1) | 体细胞突变乳腺癌 (BRCA2)美国
-
Regeneron PharmaceuticalsBayer主动,不招人
-
University Hospital, LilleMinistry of Health, France完全的
-
Heidelberg UniversityRoche Pharma AG主动,不招人II 期 1 级滤泡性淋巴瘤 | II 期 2 级滤泡性淋巴瘤 | I 期滤泡性淋巴瘤 1 级 | II 期滤泡性淋巴瘤 2 级德国
-
VA Office of Research and Development招聘中转移性去势抵抗性前列腺癌 | BARD1、BRCA1、BRCA2、BRIP1、CHEK1、芳珂、PALB2 | RAD51B、RAD51C、RAD51D 或 RAD54L 突变美国
-
Vanderbilt UniversityUniversity of California, Irvine完全的
-
Leiden University Medical CenterUniversity Medical Center Groningen; Erasmus Medical Center招聘中
-
Fondazione Policlinico Universitario Agostino Gemelli...招聘中
-
National Cancer Institute (NCI)Celgene Corporation主动,不招人Ann Arbor III 期 1 级滤泡性淋巴瘤 | Ann Arbor III 期 2 级滤泡性淋巴瘤 | Ann Arbor IV 期 1 级滤泡性淋巴瘤 | Ann Arbor IV 期 2 级滤泡性淋巴瘤 | Ann Arbor II 期 3 级连续性滤泡性淋巴瘤 | Ann Arbor II 期 3 级非连续性滤泡性淋巴瘤 | Ann Arbor III 期 3 级滤泡性淋巴瘤 | Ann Arbor IV 期 3 级滤泡性淋巴瘤 | Ann Arbor II 期 1 级连续性滤泡性淋巴瘤 | Ann Arbor II 期 1 级非连续性滤泡性淋巴瘤 | Ann Arbor II 期 2 级连续性滤泡性淋巴瘤 | Ann Arbor...美国
-
Georgetown UniversityNational Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)完全的
-
Women's College HospitalCanadian Institutes of Health Research (CIHR); London Health Sciences Centre; H. Lee Moffitt Cancer... 和其他合作者未知
-
Tango Therapeutics, Inc.招聘中乳腺癌 | 卵巢癌 | 前列腺癌 | 胰腺癌 | BRCA1突变 | BRCA-突变的卵巢癌 | BRCA 相关性乳腺癌 | HRD 阳性晚期卵巢癌美国
-
The University of New South WalesNational Health and Medical Research Council, Australia; Novo Nordisk A/S; Sydney Children's Hospitals...完全的
-
National Institute of Diabetes and Digestive and...完全的方案 #1:行为疗法 + 安慰剂或西布曲明 | 方案 #2:行为疗法 + 代餐或传统食物
-
University of California, Irvine撤销
-
Women and Infants Hospital of Rhode Island完全的
-
University of Alabama at BirminghamNational Cancer Institute (NCI)撤销卵巢癌 | brca1突变携带者 | brca2突变携带者美国
-
University of ArizonaNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)NRG Oncology完全的复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | BRCA1突变携带者 | BRCA2突变携带者 | 卵巢上皮性肿瘤美国
-
Chinese Academy of SciencesThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School未知
-
Universidade Estadual Paulista Júlio de Mesquita...University of Sao Paulo完全的
-
National Cancer Institute (NCI)完全的Ann Arbor III 期 1 级滤泡性淋巴瘤 | Ann Arbor III 期 2 级滤泡性淋巴瘤 | Ann Arbor IV 期 1 级滤泡性淋巴瘤 | Ann Arbor IV 期 2 级滤泡性淋巴瘤 | Ann Arbor II 期 3 级连续性滤泡性淋巴瘤 | Ann Arbor II 期 3 级非连续性滤泡性淋巴瘤 | Ann Arbor III 期 3 级滤泡性淋巴瘤 | Ann Arbor IV 期 3 级滤泡性淋巴瘤 | Ann Arbor II 期 1 级连续性滤泡性淋巴瘤 | Ann Arbor II 期 1 级非连续性滤泡性淋巴瘤 | Ann Arbor II 期 2 级连续性滤泡性淋巴瘤 | Ann Arbor...美国
-
University of British Columbia终止1 型糖尿病 | 怀孕 | 2型糖尿病加拿大